Influential, deep-pocketed American drug manufacturers with powerful lobbies in Washington, DC are pushing the US government to raise the pressure on New Delhi to modify policies on intellectual property rights in pharmaceuticals.
The issue has been wrinkling up Indo-US bilateral commercial ties since 2012 and was a topic of discussion both when Presiden…